For monitoring apixaban therapy, which assay is used to estimate drug concentration?

• A. PT
• B. aPTT
• C. Thrombin Time
• D. Anti-Xa chromogenic assay

Answer: (D)

The key idea is that apixaban directly inhibits factor Xa, so to estimate how much drug is in a patient’s blood you need an assay that directly measures Xa activity. An anti-Xa chromogenic assay does exactly that: it measures how much Xa activity is inhibited in the plasma and, with proper drug-specific calibrators, translates that activity into an estimated apixaban concentration. This provides a quantitative measure that can reflect different dosing or patient factors.

In contrast, routine clotting tests like PT and aPTT don’t reliably reflect apixaban levels because their results vary with the reagent used and don’t correlate consistently with drug concentration. Thrombin Time is highly sensitive to thrombin inhibitors and isn’t a reliable or standardized way to gauge Xa inhibitor levels. Therefore, the anti-Xa chromogenic assay calibrated for apixaban is the appropriate method for estimating drug concentration.